BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34689566)

  • 21. Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data.
    Guo GF; Wang YX; Zhang YJ; Chen XX; Lu JB; Wang HH; Jiang C; Qiu HQ; Xia LP
    World J Gastroenterol; 2019 Apr; 25(15):1840-1853. PubMed ID: 31057298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy and its role in gastric cancer.
    Cao Y; Luo Y; Zou J; Ouyang J; Cai Z; Zeng X; Ling H; Zeng T
    Clin Chim Acta; 2019 Feb; 489():10-20. PubMed ID: 30472237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NUCKS promotes cell proliferation and suppresses autophagy through the mTOR-Beclin1 pathway in gastric cancer.
    Zhao E; Feng L; Bai L; Cui H
    J Exp Clin Cancer Res; 2020 Sep; 39(1):194. PubMed ID: 32958058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells.
    Wang N; Zhang Q; Luo L; Ning B; Fang Y
    J Cell Physiol; 2018 Mar; 233(3):2434-2443. PubMed ID: 28776671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
    Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
    World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas.
    Chen YB; Hou JH; Feng XY; Chen S; Zhou ZW; Zhang XS; Cai MY
    J Surg Oncol; 2012 May; 105(6):542-7. PubMed ID: 22095667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.
    Bartkova J; Hoei-Hansen CE; Krizova K; Hamerlik P; Skakkebæk NE; Rajpert-De Meyts E; Bartek J
    Mol Oncol; 2014 Dec; 8(8):1667-78. PubMed ID: 25066726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
    Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological Significance of Autophagy-related Proteins and its Association With Genetic Alterations in Gliomas.
    Tamrakar S; Yashiro M; Kawashima T; Uda T; Terakawa Y; Kuwae Y; Ohsawa M; Ohata K
    Anticancer Res; 2019 Mar; 39(3):1233-1242. PubMed ID: 30842153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High LC3/Beclin Expression Correlates with Poor Survival in Glioma: a Definitive Role for Autophagy as Evidenced by In Vitro Autophagic Flux.
    Cj P; Hv E; Vijayakurup V; R Menon G; Nair S; Gopala S
    Pathol Oncol Res; 2019 Jan; 25(1):137-148. PubMed ID: 29022195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical value of CagA, c-Met, PI3K and Beclin-1 expressed in gastric cancer and their association with prognosis.
    Huang X; Wang C; Sun J; Luo J; You J; Liao L; Li M
    Oncol Lett; 2018 Jan; 15(1):947-955. PubMed ID: 29422968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of the ATM gene linked to poor prognosis for gastric cancer of different nationalities in Xinjiang.
    Han M; Ma L; Qu Y; Tang Y
    Pathol Res Pract; 2017 Aug; 213(8):908-914. PubMed ID: 28647209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of Rap1b Enhances Apoptosis and Autophagy in Gastric Cancer Cells via the PI3K/Akt/mTOR Pathway.
    Li Y; Liu Y; Shi F; Cheng L; She J
    Oncol Res; 2016; 24(5):287-293. PubMed ID: 27712585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy.
    Park JM; Huang S; Wu TT; Foster NR; Sinicrope FA
    Cancer Biol Ther; 2013 Feb; 14(2):100-7. PubMed ID: 23192274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Suppression of miR-30a/HMGA2-mediated autophagy in osteosarcoma cells impacts chemotherapeutics-induced apoptosis].
    Xia Q; Ni J; Huang J; Pan B; Yan M; Li W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):757-766. PubMed ID: 31413213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of Beclin 1 in IR-induced crosstalk between autophagy and G2/M cell cycle arrest.
    Liang N; Liu X; Zhang S; Sun H
    Cell Signal; 2019 Oct; 62():109353. PubMed ID: 31260798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
    Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
    BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinase DYRK2 acts as a regulator of autophagy and an indicator of favorable prognosis in gastric carcinoma.
    Zhang X; Xiao R; Lu B; Wu H; Jiang C; Li P; Huang J
    Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 1):112182. PubMed ID: 34749023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy.
    Ueno T; Saji S; Sugimoto M; Masuda N; Kuroi K; Sato N; Takei H; Yamamoto Y; Ohno S; Yamashita H; Hisamatsu K; Aogi K; Iwata H; Imoto S; Sasano H; Toi M
    BMC Cancer; 2016 Mar; 16():230. PubMed ID: 26984766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.